Tissue distribution of transdermal toremifene

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 6, 1997, Pages 513-520

  Soe, Lin ^a   Wurz, Gregory T ^a   Mäenpää, Juhani U ^b   Hubbard, Gene B ^c   Cadman, Timothy B ^a   Wiebe, Valerie J ^d   Theon, Alain P ^d   DeGregorio, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TURKU   (Finland)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antiestrogen; Breast cancer; Toremifene; Transdermal

Indexed keywords

4 HYDROXYTOREMIFENE; DRUG METABOLITE; ESTRADIOL; ESTROGEN RECEPTOR; TOREMIFENE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BABOON; BIOAVAILABILITY; BRAIN; BREAST CANCER; CELL CULTURE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; UTERUS;

ADMINISTRATION, CUTANEOUS; ANIMALS; ESTROGEN ANTAGONISTS; FEMALE; HORSES; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PAPIO; TISSUE DISTRIBUTION; TOREMIFENE; TUMOR CELLS, CULTURED;

EID: 0031017624     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050607     Document Type: Article

References (23)

1. Baker WJ, Wiebe VJ, Koester SK, Emshoff VD, Mäenpää JU, Wurz GT, DeGregorio MW (1992) Monitoring the chemosensitization effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cells. Breast Cancer Res Treat 24:43
2. Bardon S, Vignon F, Montcourrier P, Rochefort H (1987) Steroid receptor-mediated cytotoxicity of antiestrogen and an antiprogestin in beast cancer cells. Cancer Res 47(5): 1441
3. Brünner N, Bronzert D, Vindelov LL, Rygaard K, Spang-Thomsen M, Lippman ME (1989) Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 49(6): 1515
4. DeGregorio MW, Ford JM, Benz CC, Wiebe VJ (1989) Toremifene: pharmacologic and pharmacokinetic basis of reversing multidrug resistance. J Clin Oncol 7: 1359
5. DeGregorio MW, Mäenpää JU, Wiebe VJ (1995) Tamoxifen for the prevention of breast cancer: no. In: DeVita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology 1995. J.B. Lippincott Company, Philadelphia, p 175
6. DeMots H, Glasser SP (1989) Intermittent topical nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol 13:786
7. Ebbs JR, Roberts JV, Baum M (1987) Alternative mechanism of action of antiestrogens in breast cancer. Lancet 2:621
8. Elias JM, Margiotta M, Gabore D (1989) Sensitivity and detection efficiency of the peroxidase-antiperoxidase (PAT), avidinbiotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol 92:62
9. Erkkola R, Holma P, Jarvi T, Nummi S, Punnonen R, Raudaskoski T, Rehn K, Ryynanen M, Sipila P, Tunkelo E, et al (1991) Topical oestrogen replacement therapy in a Finnish population. Maturitas 13(4):275
10. Fisher B, Constantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from NSABP B-14. J Natl Cancer Inst 86(7):527
11. Greene GL, Nolan C, Engler JP, Jensen EV (1980) Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci USA 77(9):5115
12. Greene GL, Harris K, Bova R, Kinders R, Moore B, Nolan C (1988) Purification of T47D human progesterone receptor and immunohistochemical characterization with monoclonal antibodies. Mol Endocrinol 2:714
13. Holleran WM, Gharbo SA, DeGregorio MW (1987) Quantitation of toremifene and its major metabolites in human plasma by high-performance liquid chromatography following fluorescent activation. Anal Lett 20:871
14. Hubbard GB, Mone JP, Allan JS, Davis KJ, Leland MM, Banks PM, Smir B (1993) Spontaneously generated non-Hodgkin's lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons (Papio species). Laborat Anim Sci 43(4):301
15. Johnston SRD, Haynes BP, Smith IE, Jarman M, Sacks NPM, Ebbs SR, and Dowsett M (1993) Acquired tamoxifen resistance in human breast cancer and reduced intratumoral drug concentration. Lancet 342:1521
16. Mäenpää J, Sipila P, Kangas L, Karnani P, Gronroos M (1992) Chemosensitizing effect of an antiestrogen, toremifene, on ovarian cancer. Gynecol Oncol 46(3):292
17. Mäenpäa J, Dooley T, Wurz G, VandeBerg J, Robinson E, Emshoff V, Sipila P, Wiebe V, Day C, DeGregorio M (1993) Topical toremifene: a new approach for cutaneous melanoma? Cancer Chemother Pharmacol 32:392
18. Mauvais-Jarvis P, Baudot N, Castaigne D, Banzet P, Kuttenn F (1986) Trans-4-hydroxytamoxifen concentration and metabolism after local percutaneous administration to human breast. Cancer Res 46:1521
19. Osborne CK, Coronado E, Allred DC, Wiebe V, DeGregorio M (1991) Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxylamoxifen. J Natl Cancer Inst 83(20): 1477
20. Popli S, Daugirdas JT, Neubauer JA, Kockenberry B, Hano JE, Ing TS (1986) Topical clonidine in mild hypertension: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 146(11):2140
21. Price NM, Schmitt LG, Mcguire J, Shaw JE, Trobough G (1981) Topical scopolamine in the prevention of motion sickness at sea. Clin Pharmacol Ther 29:414
22. Valavaara R, Pyrhonen S, Heikkinen M, Rissanen P, Blanco G, Tholix E, Nordman E, Taskinen P, Holsti L, Hajba A (1988) Toremifene, a new antiestrogenic compound for treatment of advanced breast cancer. Phase II study. Eur J Cancer 24(4): 785
23. Wärri AM, Houvinen RL, Laine AM, Martikainen PM, Härkönen L (1993) Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85:1412